In the first of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss current challenges with reimbursement for AI in radiology.
|Articles|November 26, 2016
Medic Vision: ‘Only FDA-cleared 3rd Party XR-29 Solution at RSNA’
Author(s)Diagnostic Imaging Staff
Medic Vision will present at RSNA 2016 its XR-29 solution.
Advertisement
Medic Vision Imaging Solutions will present at RSNA 2016 their FDA-cleared SafeCT-29.
SafeCT-29 is the first and only FDA-cleared third party XR-29 solution that helps meet the NEMA XR-29 (Smart Dose) standard, according to a release. Practices that meet the standard can avoid a CMS penalty, which will rise to 15% in 2017 for non-compliant scanners.
SafeCT-29 is CT-vendor neutral and offers full compliance with all of the XR-29 Dose Check and RDSR requirements, according to the release. The system is fully automatic and enables the technologist to maintain their existing workflow, the release said, it connects to the CT console, analyzes data in real time, and alerts the operator if the dose is too high. After the scan, SafeCT-29 generates Radiation Dose Structured Reports, as required by the XR-29 standard, the release said.
Medic Vision will be at booth 7938.
Advertisement
Related to this article
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.
In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.
In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).
Catch up on the top radiology content of the past week.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Radiology Roundup of FDA News: September 13 — September 19
2
Does kV Still Matter in Photon-Counting CT?
3
FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET
4
Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
5